VSee Health, Inc. Receives Nasdaq Delisting Notice; Trading Suspended Aug 6

What Happened
VSee Health, Inc. (VSEE) announced that Nasdaq's Listing Qualifications Staff has determined to delist the company's securities after its closing bid price fell to $0.10 or less for ten consecutive trading days as of July 29, 2026. The company previously received a notice on September 24, 2025 that it was below Nasdaq’s $1.00 minimum bid requirement and was given two compliance periods (initially until March 27, 2026, and a subsequent extension until September 21, 2026). Nasdaq indicated trading of VSee common stock and warrants will be suspended at the opening of business on August 6, 2026 and a Form 25-NSE will be filed to remove the securities from Nasdaq.

Key Details

• Nasdaq found noncompliance with Rule 5550(a)(2) (minimum $1.00 bid) beginning Sept 24, 2025; compliance periods extended through Sept 21, 2026.
• On July 30, 2026 Nasdaq notified VSee that its shares closed at $0.10 or less for 10 consecutive trading days as of July 29, 2026, triggering delisting under Rule 5810(c)(3)(A)(iii).
• Trading of common stock and warrants to be suspended Aug 6, 2026; Form 25-NSE will be filed to remove listing/registration.
• VSee may request a hearing before the Nasdaq Hearings Panel by 4:00 p.m. ET on Aug 6, 2026 (non-refundable fee $20,000); a timely hearing request does not stay the trading suspension.

Why It Matters
A Nasdaq delisting and trading suspension can materially reduce liquidity and visibility for investors, potentially make shares harder to trade, and may lead to quotation on lower-tier markets (e.g., OTC) if relisted elsewhere. The company may appeal, but the filing makes clear there is no assurance of success. Shareholders should monitor VSee’s future SEC filings and notices from brokers for trading and custody instructions.